SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) and Astellas Pharma Inc. Announce Submission of New Drug Application for Tivozanib for the Treatment of Advanced Renal Cell Carcinoma